Have a personal or library account? Click to login
Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients? Cover

Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients?

Romanian Journal of Internal Medicine
Volume 62 (2024): Issue 1 (March 2024)
By: Mohammad S. Alkader,  Rashed Z. Altaha,  Eslam H. Jabali,  Ola A. Attieh and  Ala’ W. Matalqa  
Open Access
|Mar 2024

Authors

Mohammad S. Alkader

mohammadalkhader1984@gmail.com

Department of Clinical Oncology, Military Cancer Center, Royal Medical Services, Amman, Jordan

Rashed Z. Altaha

Department of Internal Medicine, Military Cancer Center, Royal Medical Services, Amman, Jordan

Eslam H. Jabali

Department of nuclear medicine, Royal Medical Services, Amman, Jordan

Ola A. Attieh

Department of nuclear medicine, Royal Medical Services, Amman, Jordan

Ala’ W. Matalqa

Department of Internal Medicine, Military Cancer Center, Royal Medical Services, Amman, Jordan
DOI: https://doi.org/10.2478/rjim-2023-0025 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 33 - 43
Submitted on: Jul 22, 2023
|
Published on: Mar 23, 2024
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Hyperprogressive Disease,
Immunotherapy,
Lymph Nodes,
Renal Cell Carcinoma,
Risk Factors
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2024 Mohammad S. Alkader, Rashed Z. Altaha, Eslam H. Jabali, Ola A. Attieh, Ala’ W. Matalqa, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 62 (2024): Issue 1 (March 2024)Next article